Astellas Pharma and YASKAWA Electric Corporation sign a memorandum to explore integrating pharmaceutical and robotics technologies for cell therapy.
Astellas Pharma and YASKAWA Electric Corporation sign a memorandum of understanding to explore the creation of an innovative cell therapy ecosystem through integrating pharmaceutical and robotics technologies. The collaboration focuses on digitizing cell manufacturing processes through robotics technology to address challenges in commercializing cell therapy. The memorandum is legally non-binding and will lead to further discussions between the two companies.
May 21, 2024
6 Articles